Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2007 Oct;66(10):1311-5.
doi: 10.1136/ard.2007.070755. Epub 2007 May 15.

Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations

Edward Roddy  1 , Weiya Zhang, Michael Doherty
Affiliations
Multicenter Study

Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations

Edward Roddy et al. Ann Rheum Dis. 2007 Oct.

Abstract

Objectives: To assess concordance of the management of chronic gout in UK primary care with the European League Against Rheumatism (EULAR) gout recommendations.

Methods: A postal questionnaire was sent to all adults aged >30 years registered with two general practices. Patients with possible gout attended for clinical assessment, at which the diagnosis was verified clinically. Aspects of chronic gout management, including provision of lifestyle modification advice, use of urate-lowering therapies (ULT) including dose titration to serum urate (SUA) level, prophylaxis against acute attacks, and diuretic cessation were assessed in accordance with the EULAR recommendations.

Results: Of 4249 (32%) completed questionnaires returned, 488 reported gout or acute attacks and were invited for clinical assessment. Of 359 attendees, 164 clinically confirmed cases of gout were identified. Advice regarding alcohol consumption was recalled by 59 (41%), weight loss by 36 (25%) and diet by 42 (29%). Allopurinol was the only ULT used and was taken by 44 (30%); 31 (70%) were taking 300 mg daily. Mean SUA was lower in allopurinol users than non-users (318 vs 434 micromol/l) and was less often >360 micromol/l in allopurinol users (23% vs 75%). Eight patients had recently commenced allopurinol; two of these also were taking prophylactic colchicine or non-steroidal anti-inflammatory drugs. Of 25 patients with diuretic-induced gout, 16 (64%) were still taking a diuretic.

Conclusion: Treatment of chronic gout is often suboptimal and poorly concordant with EULAR recommendations. Lifestyle advice is infrequently offered, and allopurinol is restricted to a minority. Persistent hyperuricaemia was often seen in allopurinol non-users, but was also in allopurinol users, suggesting that doses >300 mg are often necessary.

PubMed Disclaimer

Conflict of interest statement

Competing interests: We received an unrestricted grant from Ipsen, France, which contributed towards the cost of the questionnaire survey.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Mikuls T R, Farrar J T, Bilker W B, Fernandes S, Schumacher H R, Jr, Saag K G. Gout epidemiology: results from the UK General Practice Research Database, 1990–1999. Ann Rheum Dis 200564267–272. - PMC - PubMed
    1. Harris C M, Lloyd D C, Lewis J. The prevalence and prophylaxis of gout in England. J Clin Epidemiol 1995481153–1158. - PubMed
    1. Lawrence R C, Helmick C G, Arnett F C, Deyo R A, Felson D T, Giannini E H.et al Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 199841778–799. - PubMed
    1. Zhang W, Doherty M, Pascual E, Bardin T, Barskova V, Conaghan P.et al EULAR evidence based recommendations for gout. Part I. Diagnosis: Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006651301–1311. - PMC - PubMed
    1. Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P.et al EULAR evidence based recommendations for gout. Part II. Management: Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006651312–1324. - PMC - PubMed

Publication types

MeSH terms